Hearing, balance and connection—all easy to take for granted, but profoundly impactful when disrupted. Disorders of the ear are often associated with feelings of frustration, decreased social interaction and depression. At Otonomy, our focus is on making new treatments a reality for the millions living with the debilitating, daily impact of these conditions.
Location: United States, California, San Diego
Total raised: $143.9M
Investors 4
Date | Name | Website |
- | Domain Ass... | domainvc.c... |
- | Aperture V... | aperturevp... |
- | Perceptive... | perceptive... |
- | TPG | tpg.com |
Funding Rounds 4
Date | Series | Amount | Investors |
30.04.2014 | Series D | $49M | - |
04.09.2013 | Series C | $45.9M | - |
30.08.2010 | Series B | $38.5M | - |
11.06.2010 | Series A | $10.5M | - |
Mentions in press and media 25
Date | Title | Description | Source |
08.04.2021 | OTONOMY, INC. Otonomy Announces Pricing of $30.1 Million Pu... | SAN DIEGO, April 07, 2021 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical comp... | marketscre... |
28.07.2017 | A race is underway to repair our hearing — with medicine | On any bustling city street, in the middle of the afternoon, it’s probably the case that half or mor... | techcrunch... |
26.09.2016 | Can a Pill Fix Your Hearing? | Listen up, baby boomers (and others): Your damaged hearing may soon be improved—and it won’t require... | fortune.co... |
29.06.2016 | The biotech IPO feast flags as investors lose their appeti... | There was a time after the 2008 crash that biotech IPOs were about as popular as snow in March. B... | endpts.com... |
12.01.2016 | Otonomy Inc. Announces Close of $115 Million Public Offering | San Diego drug developer Otonomy Inc. announced Jan 12 the closing of its $115 million public offeri... | sdbj.com/n... |
15.10.2015 | Third Rock hearing loss startup Decibel Therapeutics launche... | Indeed, Third Rock companies generally take this broad scale approach to their respective fields – t... | medcitynew... |
14.08.2014 | Otonomy Announces $100M IPO | Venture-backed Otonomy, a San Diego, CA-based developer of drug therapies for the inner and middle e... | finsmes.co... |
13.07.2014 | Fresh off Phase III success, Otonomy shoots for an $86M IPO | San Diego biotech Otonomy isn't biding its time, filing to go public in an $86.3 million IPO just th... | fiercebiot... |
30.04.2014 | Otonomy Inks $49M in Oversubscribed Round | SAN DIEGO, CA, Biopharmaceutical company developing and commercializing innovative therapeutics fo... | vcnewsdail... |
30.04.2014 | Otonomy Gets $49M In New Funding | San Diego-based biopharmaceuticals developer Otonomy--which is developing treatments for inner and m... | socaltech.... |
Show more